Doctors Call for Uninterrupted Health Insurance Coverage for 10,000 Inflammatory Bowel Disease Patients in Taiwan

AI Summary (NQ-processed)

In Taiwan, nearly 10,000 patients with Inflammatory Bowel Disease (IBD) face the risk of treatment interruption and recurrent surgeries due to current National Health Insurance (NHI) regulations. The medical community is urging a re-evaluation of NHI reimbursement rules to allow continuous access to advanced treatments like biologics. They argue that discontinuing treatment leads to higher rates of relapse and complications, ultimately resulting in greater long-term healthcare costs.